Somavert (pegvisomant) - Important Safety Information from Pfizer as approved by the Irish Medicines Board
03 April 2012
Important Safety Information communication from Pfizer informing Somavert prescribers that an improved drug substance manufacturing process which improves the quality profile of the B2036 protein (pegvisomant) is now in place.
Important Safety Information - Somavert (pegvisomant)